This compound is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is a quinazoline derivative with a complex structure that includes an amide, amine, and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
pharmaceutical raw material
(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
pharmaceutical raw material
Afatinib Impurity 18
pharmaceutical intermediate
Afatinib D6
pharmaceutical raw material
(-)-epiafzelechin
pharmaceutical raw material
Prasteronyl Abiraterone
pharmaceutical raw material
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
pharmaceutical raw material
Beta-Epoxyabiraterone acetate
pharmaceutical raw material
(E)-N-[4-(4-chloro-3-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
CIGJZGGVLAOLAG-CWDCEQMOSA-N
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)F)O[C@H]4CCOC4
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.